Synthorx
develops and commercializes novel protein therapeutics for the treatment of cancer, immune-oncology and autoimmune disorders... Read moreSynthorx
develops and commercializes novel protein therapeutics for the treatment of cancer, immune-oncology and autoimmune disorders... Read more
2014
PrivateSubsidiary of Sanofi S.A
News
Jan 24, 2020
FinSMEs
Synthorx: Sanofi Closes Purchase of Synthorx
Jan 24, 2020
PMLiVE
Synthorx: Sanofi completes acquisition of immuno-oncology specialist Synthorx
Jan 23, 2020
BioSpace
Synthorx: Sanofi Completes Acquisition of Synthorx, Inc.
Jan 23, 2020
BioPortfolio
Synthorx: Sanofi Sanofi Completes Acquisition of Synthorx Inc.
Dec 24, 2019
Seeking Alpha
Synthorx: Synthorx +4% after revealing another bidder
Dec 21, 2019
MarketScreener
Synthorx: SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - BOLD, INST, THOR
Dec 17, 2019
Leaders League
Synthorx: Cooley Advises Synthorx on $2.5 Billion Sanofi Purchase
Dec 15, 2019
San Diego Business Journal
Synthorx: French Pharma Company to Pay $2.5 Billion for Synthorx
Dec 10, 2019
MarketScreener
Synthorx: Monteverde & Associates PC Announces an Investigation of ArQule, Inc - ARQL
Dec 10, 2019
BioPharma-Reporter
Synthorx: Sanofi to add Synthorx for $2.5bn, eyeing oncology combinations
Synthorx Competitors
1
2
3
4
5
6